Prevention of hepatocellular carcinoma in patients with chronic hepatitis B

doi:10.4292/wjgpt.v5.i3.175

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3527)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

263

WORD

255

HTML

1929

Figures (1-2)

214

Sum=2661

Aug 6, 2014 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Pharmacol Ther. Aug 6, 2014; 5(3): 175-182
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.175

Full Size Figure Download Figure

Figure 2 Mechanisms of chronic hepatitis B virus infection-related hepato-carcinogenesis[27-32]. cccDNA: Covalently closed circular DNA. HBV: Hepatitis B virus.

Citation: Fernández-Rodríguez CM, Gutiérrez-García ML. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B. World J Gastrointest Pharmacol Ther 2014; 5(3): 175-182
URL: https://www.wjgnet.com/2150-5349/full/v5/i3/175.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v5.i3.175